Brian Ferguson
@viropractor.bsky.social
Professor of viral immunity at Cambridge Uni, Dept of Pathology. Mainly poxviruses and innate immunity. www.fergusonlab.path.cam.ac.uk
There isn’t a ‘normal’ dose but this is too high. One big problem for gene therapy is targeting and modifying enough of the correct cells to make a physiological impact on disease. Hence the trials of large doses.
July 31, 2025 at 2:51 PM
There isn’t a ‘normal’ dose but this is too high. One big problem for gene therapy is targeting and modifying enough of the correct cells to make a physiological impact on disease. Hence the trials of large doses.
to early to say what the future holds, but will certainly be much harder to get past the regulatory agencies
July 27, 2025 at 1:33 PM
to early to say what the future holds, but will certainly be much harder to get past the regulatory agencies